SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control

Magdalene K. Montgomery, Jacqueline Bayliss, Camille Devereux, Ayenachew Bezawork-Geleta, David Roberts, Cheng Huang, Ralf B. Schittenhelm, Andrew Ryan, Scott L. Townley, Luke A. Selth, Trevor J. Biden, Gregory R. Steinberg, Dorit Samocha-Bonet, Ruth C. R. Meex, Matthew J. Watt*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number8048
Number of pages13
JournalScience Translational Medicine
Volume12
Issue number559
DOIs
Publication statusPublished - 2 Sep 2020

Keywords

  • INSULIN-RESISTANCE
  • BINDING PROTEIN
  • CREB
  • GLUCONEOGENESIS
  • TRANSCRIPTION
  • METABOLISM
  • LIVER
  • PHOSPHORYLATION
  • IDENTIFICATION
  • EXERCISE

Cite this